Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001065953 | SCV001230945 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2023-07-10 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with CAPN3-related conditions. For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 859768). This variant is present in population databases (no rsID available, gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln188Asnfs*32) in the CAPN3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CAPN3 are known to be pathogenic (PMID: 10330340, 15689361). |
Revvity Omics, |
RCV001784621 | SCV002018042 | likely pathogenic | not provided | 2023-11-30 | criteria provided, single submitter | clinical testing | |
Laboratory of Medical Genetics, |
RCV001065953 | SCV002577414 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2022-07-14 | criteria provided, single submitter | clinical testing | PVS1, PM2, PM3, PP5 |